alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 11,276–11,300 of 27,380 studies, newest first · page 452 of 1096.

August 2020 25

  1. 2020-08-21

    Multimodal in vivo and postmortem assessments of tau in Lewy body disorders

    ✓ Peer-reviewed Brain scans and imaging Neurobiology of aging

    Key finding: Higher retention was associated with higher CSF total-tau levels (p = 0.04), poorer domain-specific cognitive performance (p = 0.02-0.04), and greater severity of neuropathological tau in corresponding regions.

    Full summary, score breakdown and related studies → Original source

  2. 2020-08-21

    A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders

    ✓ Peer-reviewed Genetics Nature communications

    Key finding: We show that the common genetic risk for Parkinson's disease (PD) is associated with dopaminergic neuron (DaN)-specific gene expression, including mitochondrial functioning, protein folding and ubiquitination pathways. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2020-08-21

    The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia

    ✓ Peer-reviewed Down syndrome and Alzheimer's Antioxidants (Basel, Switzerland)

    Key finding: Down syndrome (DS) is the most common genetic cause of intellectual disability that is associated with an increased risk to develop early-onset Alzheimer-like dementia (AD). +2 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2020-08-20

    Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

    ✓ Peer-reviewed Tau biomarkers PLoS medicine

    Key finding: The ε4 allele of apolipoprotein E (APOE) gene and increasing age are two of the most important known risk factors for developing Alzheimer disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2020-08-20

    Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia

    ✓ Peer-reviewed Risk genes beyond APOE Frontiers in aging neuroscience

    Key finding: The neurodegenerative disease became known as Alzheimer's disease (AD) and is the most common cause of dementia worldwide. +3 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2020-08-20

    The Role of EEG in the Diagnosis, Prognosis and Clinical Correlations of Dementia with Lewy Bodies-A Systematic Review

    ✓ Peer-reviewed Digital health tools Diagnostics (Basel, Switzerland)

    Key finding: We included 43 studies comparing EEG in DLB with other diagnoses, 42 of them included a comparison of DLB with AD, 10 studies compared DLB with Parkinson's disease dementia, and 6 studies compared DLB with other dementias. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2020-08-19

    Continuity of care and health care cost among community-dwelling older adult veterans living with dementia

    ✓ Peer-reviewed Costs and economics Health services research

    Key finding: Mean BBC in FY 2014 was 0.32; mean total cost in FY 2015 was $35 425. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2020-08-19

    User-Centered Design and Evaluation of a Web-Based Decision Aid for Older Adults Living With Mild Cognitive Impairment and Their Health Care Providers: Mixed Methods Study

    ✓ Peer-reviewed Digital health tools Journal of medical Internet research

    Key finding: The thematic analysis revealed 3 major issues. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2020-08-19

    Digital biomarker-based individualized prognosis for people at risk of dementia

    ✓ Peer-reviewed Digital health tools Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Digital biomarker prognostic models can be a useful tool to assist large-scale population screening for the early detection of cognitive impairment and patient monitoring over time.

    Full summary, score breakdown and related studies → Original source

  10. 2020-08-19

    The Effects of Age-Related Hearing Loss on the Brain and Cognitive Function

    ✓ Peer-reviewed Prevention and risk Trends in neurosciences

    Key finding: Recently, hearing loss has been identified as potentially the most modifiable risk factor for dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2020-08-18

    Informal and formal care among persons with dementia immediately before nursing home admission

    ✓ Peer-reviewed Caregiving BMC geriatrics

    Key finding: A total of 395 persons with dementia were included. +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2020-08-18

    Education, intelligence, and amyotrophic lateral sclerosis: A Mendelian randomization study

    ✓ Peer-reviewed Risk factors Annals of clinical and translational neurology

    Key finding: Genetically predisposition to longer educational attainment and harder math class taken were associated with significantly lower statistical odds ratio of ALS. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2020-08-18

    Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond

    ✓ Peer-reviewed Treatments Psychiatry research

    Key finding: The objective of this review is to highlight the potential of the galantamine-memantine combination to conduct randomized controlled trials (RCTs) in AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2020-08-18

    Disease duration in autosomal dominant familial Alzheimer disease: A survival analysis

    ✓ Peer-reviewed Risk genes beyond APOE Neurology. Genetics

    Key finding: Estimated mean survival was 11.6 (10.4-12.9) years and was similar for APP and PSEN1 mutations. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2020-08-18

    Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: The combination BBBM with MMSE is projected to increase the efficiency and value of the triage process for DMT eligibility.

    Full summary, score breakdown and related studies → Original source

  16. 2020-08-18

    P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice

    ✓ Peer-reviewed Disease mechanisms Molecular neurodegeneration

    Key finding: The oral administration of P2RX7 inhibition mitigates disease phenotypes in P301S mice, likely by suppressing release of microglial exosomes. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2020-08-18

    Device-assessed physical activity and sedentary behavior in a community-based cohort of older adults

    ✓ Peer-reviewed Disparities BMC public health

    Key finding: Our recruitment rate demonstrates the feasibility of cohort participants to wear two devices that measure sedentary time and physical activity.

    Full summary, score breakdown and related studies → Original source

  18. 2020-08-18

    Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field

    ✓ Peer-reviewed Treatments Journal of neurology

    Key finding: To identify people in this early disease stage, criteria for 'prodromal PD' have been proposed-describing people with one or more specific features that jointly constitute a variably increased risk of developing clinically manifest PD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  19. 2020-08-18

    Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: Recent functional magnetic resonance imaging studies have demonstrated that moment-to-moment variability in the blood oxygen level-dependent (BOLD) signal is related to age differences, cognition, and symptomatic Alzheimer's disease (AD).

    Full summary, score breakdown and related studies → Original source

  20. 2020-08-17

    Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The Washington University School of Medicine Knight Alzheimer Disease Research Center's "African American Participation in Alzheimer Disease Research: Effective Strategies" Workshop convened to address a major limitation of the ongoing scientific progress regarding Alzheimer's disease and related dementias (ADRD): participants in most ADRD research programs overwhelmingly have been limited to non-Hispanic white persons, thus precluding knowledge as to how ADRD may be represented in non-white individuals. +1 more finding

    Full summary, score breakdown and related studies → Original source

  21. 2020-08-17

    Repurposed agents in the Alzheimer's disease drug development pipeline

    ✓ Peer-reviewed Drug development Alzheimer's research & therapy

    Key finding: We identified 53 clinical trials involving 58 FDA-approved agents. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2020-08-17

    QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine

    ✓ Peer-reviewed Treatments Therapeutic advances in drug safety

    Key finding: A total of 13 case reports were found (10 for donepezil, 2 for galantamine and 1 for rivastigmine) with rate corrected QT interval (QTc) prolongation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2020-08-17

    The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability

    ✓ Peer-reviewed Disease mechanisms Cells

    Key finding: An altered intestinal permeability, a sign of a perturbed barrier function, has during the last decade been associated with several chronic conditions, including diseases originating in the gastrointestinal tract but also diseases such as Alzheimer and Parkinson disease.

    Full summary, score breakdown and related studies → Original source

  24. 2020-08-17

    Using the COM-B model to identify barriers and facilitators towards adoption of a diet associated with cognitive function (MIND diet)

    ✓ Peer-reviewed Prevention trials Public health nutrition

    Key finding: This study provides insight into the personal, social and environmental factors that participants report as barriers and facilitators to the adoption of the MIND diet among middle-aged adults living in the UK. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2020-08-17

    Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Molecular neurodegeneration

    Key finding: Compared to controls, mean CSF NPTX2 levels were lower in DS at all AD stages; aDS (0.6-fold, adj.p 0.07). +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →